SecBot SecBot

TXMD

TherapeuticsMD, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0000025743 Biotech & Drug Discovery
$1.77 −0.03 (−1.66%)
Oct 27 4:00 PM ET · prev $1.80
Market cap
$20.8M
Nano cap
Next earnings
Nov 10
in 14 days
1 year
+35.1%
from $1.31 · Oct 27
30 days
−15.3%
from $2.09
52-week range
$1.15–2.77
−36% from high · low Nov 3
Avg volume 20D
20.3K
Oct 19 spike 119.9K
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 10, 2026
Strongest BEARISH TherapeuticsMD reported Q2 2026 results showing declining license revenue ($869K vs $952K YoY) and net…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Jul 31 Short interest falls 32.5% to 29.1K

Signal stack

Where each data set points today.

  • InstitutionsBULLISH

    Q2 2026: 6 added (0 new), 0 trimmed or exited.

  • TrendDOWNTREND

    14% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCADD86,095$190.3K
DIMENSIONAL FUND ADVISORS LPADD19,719$43.6K
OSAIC HOLDINGS, INC.DOUBLED15,198$33.6K
UBS Group AGDOUBLED4,660$10.3K
ROYAL BANK OF CANADADOUBLED833$1.0K
Farther Finance Advisors, LLCADD39$86.00
RENAISSANCE TECHNOLOGIES LLCADD146,200$295.3K
UBS Group AGTRIM331$669.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2023
Recent actions
DateFirmActionRating
Aug 17, 2023Cantor Fitzgerald
REITERATE
REITERATENeutral
Jul 13, 2022Cantor Fitzgerald
REITERATE
REITERATENeutral
Jun 7, 2022HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral

Earnings setup

Estimates
Nov 10
reports in 14 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
TXMD Q3 2026 Earnings Scheduled — 2026-11-10
Recent
Aug 10, 2026
Earnings date
TXMD Q2 2026 Earnings Scheduled — 2026-08-10
May 11, 2026
Earnings date
TXMD Q1 2026 Earnings Scheduled — 2026-05-11
Mar 25, 2026
Earnings date
TXMD Q4 2025 Earnings After Market Close — 2026-03-25

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 11, 2026 SEC
TherapeuticsMD reported Q2 2026 results showing declining license revenue ($869K vs $952K YoY) and net income ($164K…
8-K — Impact 5/10
Aug 10, 2026 Earnings calendar
TXMD Q2 2026 Earnings Scheduled — 2026-08-10
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — ADD
86,095 shares ($190.3K)
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP — ADD
19,719 shares ($43.6K)
May 12, 2026 SEC
TherapeuticsMD reported Q1 2026 results: net income from continuing operations of $103K vs a net loss of $636K in Q1…
8-K — Impact 4/10
Mar 30, 2026 SEC
TherapeuticsMD reported full-year 2025 financial results showing improved net loss of $(0.7)M (from $(2.3)M in 2024)…
8-K — Impact 5/10

SecBot reports

4 filings · 0 bullish · 2 bearish · 1 mixed · 1 neutral
All TXMD filing & press-release reports (4)